艾意凯：2024印度医疗器械报销现状及未来前景报告（英文版）

Establishment of a strong health technology assessment (HTA) architecture is increasingly seen as a key indicator of the maturity of the reimbursement process in any health system. The systemic capability to conduct HTAs demonstrates a strong intent to drive equitable access to effective, high-quality health technologies and services, driven by a holistic, patient-centric view beyond mere cost savings. Additionally, HTA capabilities demonstrate that payors have the sophistication necessary to